Most stocks in solar (SLRC, CSIQ, TSL, SCTY) are relatively cheap in the $10-20 range with some in the $40 range like FSLR, and the solar market seems to be favored for high growth in the future. Is there potential for high and steady growth with minimal risk?
Two pharmaceutical research companies in particular (AUPH and APTO) are developing medications for serious illnesses, they have faced problems with clinical trials earlier this year which significantly reduced their stock prices and now while clinical trials are still in progress analyists are predicting the possibility for long term growth. Is it worth investing heavily now while prices are low in the single digits?
Submitted October 24, 2016 at 03:42AM by Krsnatvam http://ift.tt/2emqWZs
No comments:
Post a Comment